Use of asthma medication during pregnancy and risk of specific congenital anomalies: A European case-malformed control study

Journal of Allergy and Clinical Immunology

Volumn 136, Issue 6, 2015, Pages 1496-1502.e7

  Garne, Ester ^a   Hansen, Anne Vinkel ^a   Morris, Joan ^b   Zaupper, Louise ^a   Addor, Marie Claude ^c   Barisic, Ingeborg ^d   Gatt, Miriam ^e   Lelong, Nathalie ^f   Klungsøyr, Kari ^g   O'Mahony, Mary ^h   Nelen, Vera ⁱ   Neville, Amanda J ^j   Pierini, Anna ^k   Tucker, David ^l   De Walle, Hermien ^m   Wiesel, Awi ⁿ   Loane, Maria ^o   Dolk, Helen ^o  

^a KOLDING HOSPITAL   (Denmark)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^c Division of Medical Genetics   (Switzerland)

^d Croatia   (Croatia)

^e Direct for Health Information and Research   (United States)

^f PARIS DESCARTES UNIVERSITY   (France)

^g UNIVERSITY OF BERGEN   (Norway)

^h HEALTH SERVICE EXECUTIVE   (Ireland)

ⁱ Provincial Institute for Hygiene   (Belgium)

^j UNIVERSITY HOSPITAL OF FERRARA   (Italy)

^k INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

^l PUBLIC HEALTH WALES   (United Kingdom)

^m UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

ⁿ UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^o UNIVERSITY OF ULSTER   (United Kingdom)

more..

Author keywords

Asthma medication; congenital anomalies; first trimester exposure; inhaled corticosteroids; inhaled 2 agonists; pregnancy

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; CROMOGLYCATE DISODIUM; LEUKOTRIENE RECEPTOR BLOCKING AGENT; NEDOCROMIL; SALBUTAMOL; STEROID; THEOPHYLLINE; ANTIASTHMATIC AGENT;

ANUS ATRESIA; ARTICLE; ASTHMA; CLEFT LIP; CLEFT PALATE; CONGENITAL HEART MALFORMATION; CONGENITAL MALFORMATION; CONTROLLED STUDY; DRUG EXPOSURE; DRUG USE; EUROPE; FALLOT TETRALOGY; FIRST TRIMESTER PREGNANCY; GASTROSCHISIS; HUMAN; HYPOSPADIAS; KIDNEY DYSPLASIA; PRIORITY JOURNAL; RISK ASSESSMENT; SPINAL DYSRAPHISM; CASE CONTROL STUDY; CONGENITAL ABNORMALITIES; FEMALE; ODDS RATIO; PREGNANCY; PRENATAL EXPOSURE; RISK;

ADRENAL CORTEX HORMONES; ADRENERGIC BETA-2 RECEPTOR AGONISTS; ANTI-ASTHMATIC AGENTS; ASTHMA; CASE-CONTROL STUDIES; CONGENITAL ABNORMALITIES; EUROPE; FEMALE; HUMANS; ODDS RATIO; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PRENATAL EXPOSURE DELAYED EFFECTS; RISK;

EID: 84952637982     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2015.05.043     Document Type: Article

References (29)

1. X. Zhang, T. Morrison-Carpenter, J.B. Holt, and D.B. Callahan Trends in adult current asthma prevalence and contributing risk factors in the United States by state: 2000-2009 BMC Public Health 13 2013 1156
2. H.L. Kwon, K. Belanger, and M.B. Bracken Asthma prevalence among pregnant and childbearing-aged women in the United States: estimates from national health surveys Ann Epidemiol 13 2003 317 324
3. V.E. Murphy, and P.G. Gibson Asthma in pregnancy Clin Chest Med 32 2011 93 110
4. R.A. Charlton, A. Hutchison, K.J. Davies, and C.S. de Vries Asthma management in pregnancy PLoS One 8 2013 e60247
5. J.M. Clark, E. Hulme, V. Devendrakumar, M.A. Turner, P.N. Baker, C.P. Sibley, and et al. Effect of maternal asthma on birthweight and neonatal outcome in a British inner-city population Paediatr Perinat Epidemiol 21 2007 154 162
6. M. Tegethoff, J. Olsen, E. Schaffner, and G. Meinlschmidt Asthma during pregnancy and clinical outcomes in offspring: a national cohort study Pediatrics 132 2013 483 491
7. National Heart, Lung and Blood Institute; National Asthma Education and Prevention Program Asthma and pregnancy working Group NAEPP Expert Panel Report. Managing asthma during pregnancy. Recommendations for pharmacologic treatment - 2004 update J Allergy Clin Immunol 115 2005 34 46
8. British Thoracic Society/Scottish Intercollegiate Guidelines Network British guidelines on asthma management: a national clinical guideline Thorax 63 suppl 4 2008 12147 12158
9. M.P. Dombrowski, and M. Schatz ACOG Committee on Practice Bulletins-Obstetrics. ACOG practice bulletin: clinical management guidelines for obstetrician-gynecologists number 90, February 2008: asthma in pregnancy Obstet Gynecol 111 2008 457 464
10. V.E. Murphy, and J.A. Namazy A meta-analysis of adverse perinatal outcomes in women with asthma BJOG 118 2011 1314 1323
11. R.E. Rocklin Asthma, asthma medications and their effect on maternal/fetal outcomes during pregnancy Reprod Toxicol 32 2011 189 197
12. V.E. Murphy, G. Wang, J.A. Namazy, H. Powel, P.G. Gibson, C. Chambers, and et al. The risk of congenital malformations, perinatal mortality and neonatal hospitalisation among pregnant women with asthma: a systematic review and meta-analysis BJOG 120 2013 812 822
13. L. Blais, F.Z. Kettani, N. Elftouh, and A. Forget Effect of maternal asthma on the risk of specific congenital malformations: a population-based cohort study Birth Defects Res A Clin Mol Teratol 88 2010 216 222
14. J.P.W. Munsie, S. Lin, M.L. Browne, K.A. Campbell, A.R. Caton, E.M. Bell, and et al. Maternal bronchodilator use and the risk of orofacial clefts Hum Reprod 26 2011 3147 3154
15. S. Lin, J.P. Munsie, M.L. Herft-Losavio, E. Bell, C. Druschel, P.A. Romitti, and et al. Maternal asthma medication and the risk of gastroschisis Am J Med Genet 168 2008 73 79
16. S. Lin, J.P. Munsie, M.L. Herdt-Losavio, C.M. Druschel, K. Campbell, M.L. Browne, and et al. Maternal asthma medication use and the risk of selected birth defects Pediatrics 129 2012 317 324
17. L. Blais, and A. Forget Asthma exacerbations during first trimester of pregnancy and the risk of congenital malformations among asthmatic women J Allergy Clin Immunol 121 2008 1379 1384
18. R.R. Vatti, and S.S. Teuber Asthma and pregnancy Clin Rev Allergy Immunol 43 2012 45 56
19. E.B. Hook What kind of controls to use in case-control studies of malformed infants: recall bias versus "teratogen non-specificity" bias Teratology 61 2000 325 326
20. J. Jentink, M. Loane, H. Dolk, I. Barisic, E. Garne, J.K. Morris, and et al. Valproate acid monotherapy in pregnancy and major congenital malformations N Engl J Med 362 2010 2185 2193
21. P. Boyd, M. Haussler, I. Barisic, M. Loane, E. Garne, and H. Dolk Paper 1: the EUROCAT network - organization and processes Birth Defects Res A Clin Mol Teratol 91 2011 S2 S15
22. R. Greenlees, A. Neville, M.-C. Addor, E. Amar, L. Arriola, M. Bakker, and et al. Paper 6: EUROCAT member registries: organization and activities Birth Defects Res A Clin Mol Teratol 91 2011 S51 S100
23. P. Pradat, E. Robert-Gnansia, G.L. Di Tanna, A. Rosano, A. Lisi, and P. Mastroiacovo First trimester exposure to corticosteroids and oral clefts Birth Defects Res Part A Clin Mol Teratol 67 2003 968 970
24. B. Källen, and P.O. Oalusson Use of anti-asthmatic drugs during pregnancy. 3. Congenital malformations in the fetus Eur J Clin Pharmacol 63 2007 383 388
25. S. Lin, M. Herdt-Losavio, L. Gensburg, E. Marshall, and C. Druschel Maternal asthma, asthma medication use and the risk of congenital heart defects Birth Defects Res A Clin Mol Teratol 85 2009 161 168
26. S. Eltonsy, A. Forget, and L. Blais Beta-2-agonists use during pregnancy and the risk of congenital malformations Birth Defects Res A Clin Mol Teratol 91 2011 937 947
27. S.L. Carmichael, C. Ma, M.M. Werler, R.S. Olney, and G.M. Shaw Maternal corticosteroid use and hypospadias J Pediatr 155 2009 39 44
28. B. Kâllen Maternal asthma and use of antiasthmatic drugs in early pregnancy and congenital malformations in the offspring J Pulm Respir Med 4 2014 166
29. T.Y. Tan, N. Kilpatrick, and P.G. Farlie Developmental and genetic perspectives on Pierre Robin sequence Am J Med Genet C Semin Med Genet 163C 2013 295 305